Allergic Reactions and Antihistamines: Histamine, H1 Receptors and Anaphylaxis

A patient receives an antibiotic. A few minutes later they say their palms feel itchy. Then you notice raised red wheals across their chest. Their lips look slightly swollen.

At this point it is tempting to reduce the whole situation to one thought: allergic reaction, give an antihistamine.

But what if the rash starts fading and, ten minutes later, the patient says their throat feels tight?

That is where simply knowing that antihistamines are “allergy medicines” stops being enough. To understand what matters clinically, you need to know what the immune system has actually done, why histamine causes some of the symptoms you can see, and why blocking histamine is very different from treating anaphylaxis.

So start with the patient, then work backwards.

Why did the reaction happen so quickly?

For a typical immediate IgE-mediated allergic reaction, this is usually not the immune system meeting the allergen for the first time.

At some earlier point, the person became sensitised. Their immune system recognised an allergen and produced allergen-specific immunoglobulin E, usually shortened to IgE. Those IgE antibodies attached to high-affinity receptors on cells including mast cells.

You can picture the mast cell as being primed. The IgE is already sitting on its surface, waiting.

When the person encounters that allergen again, the allergen can cross-link neighbouring IgE molecules. That activates the mast cell and triggers degranulation.

Degranulation sounds complicated, but the idea is straightforward: the mast cell rapidly releases preformed inflammatory mediators stored inside it, including histamine, while other mediators are generated as the reaction develops.

So the useful pathway is:

Allergen → IgE cross-linking on a sensitised mast cell → mast-cell activation and degranulation → histamine and other mediators → clinical effects.

This is why an immediate reaction can develop within minutes. The immune system does not need to build the response from scratch. The person has already been sensitised.

There is an important caveat here. Not every allergic or anaphylactic reaction follows a simple IgE pathway, and anaphylaxis should never be ruled in or out by trying to identify the exact immunological mechanism at the bedside. But IgE-mediated mast-cell activation gives you a very useful model for understanding many immediate allergic reactions.

Histamine has been released. What does that actually do?

This is the point where “histamine causes allergy symptoms” is usually taught and then abandoned. It is much more useful to follow the effects through the body.

Histamine acts through several receptor types. For this topic, the H1 receptor is particularly important because many of the familiar immediate allergic symptoms are related to H1 activity.

One effect is vasodilation. Small blood vessels widen.

Another is increased vascular permeability. The endothelial barrier becomes more permeable, allowing fluid to move from the intravascular space into surrounding tissues more readily.

Now go back to the patient.

Fluid moving into superficial tissues helps explain the raised swelling of urticaria. Histamine acting on sensory nerves contributes to itching. Increased permeability in deeper tissues can contribute to angioedema, which may affect areas such as the lips and eyelids.

The same basic physiology becomes much more serious when it is widespread. If blood vessels dilate throughout the circulation and fluid moves out of the vascular space, effective circulating volume falls. Venous return can fall. Blood pressure can fall. Tissue perfusion can become compromised.

So hypotension in anaphylaxis is not an unrelated symptom sitting at the bottom of a list. It follows from what the inflammatory response is doing to the circulation.

The respiratory system can also be affected. Upper-airway mucosal oedema can narrow the airway. Lower-airway involvement can include bronchoconstriction and increased respiratory difficulty. Other inflammatory mediators contribute too, which is one reason it is misleading to think of anaphylaxis as simply “too much histamine”.

That distinction becomes very important when we get to treatment.

So why does an antihistamine help the rash?

An H1 antihistamine reduces histamine's effects at H1 receptors.

If histamine is driving itching, redness and urticaria, blocking H1 receptors can reduce those symptoms. This is why oral antihistamines such as cetirizine may be useful for an allergic rash when there are no life-threatening airway, breathing or circulation features.

But notice what the antihistamine has not done.

It has not switched off the entire allergic response. It has not removed every inflammatory mediator. It has not rapidly corrected severe vasodilation, restored a failing circulation, reversed dangerous upper-airway oedema or provided the broad physiological effects needed in anaphylaxis.

This gives you a much better way of remembering the role of antihistamines:

Antihistamines are useful for histamine-mediated symptoms, particularly skin symptoms. They are not the treatment for the life-threatening airway, breathing or circulation problems of anaphylaxis.

Resuscitation Council UK makes this distinction very clearly. Antihistamines are not recommended for treating airway, breathing or circulation problems in anaphylaxis and must not delay intramuscular adrenaline.

But the patient has a rash. Does that mean anaphylaxis?

No.

A widespread itchy urticarial rash can look alarming while the patient's airway, breathing and circulation remain stable. That is an allergic reaction, but the presence of a rash alone does not automatically make it anaphylaxis.

Now turn that around: the absence of a rash does not rule anaphylaxis out either.

Current UK guidance describes anaphylaxis as a rapidly developing reaction involving life-threatening problems with the airway, breathing and/or circulation. Skin and mucosal changes are common, but they are not required.

This matters on placement because skin is visually persuasive. A huge rash gets everyone's attention. A patient whose rash is fading can look reassuring. Neither tells you, by itself, what is happening to their airway or circulation.

Keep assessing the patient.

A hoarse or changing voice, throat tightness, stridor, tongue swelling or increasing difficulty swallowing should make you think about the airway. Wheeze, tachypnoea, increasing work of breathing, falling oxygen saturations or exhaustion should make you think about breathing. Hypotension, tachycardia, pallor, clamminess, dizziness, collapse, confusion or reduced consciousness should make you think about circulation.

Gastrointestinal symptoms such as abdominal pain or vomiting can occur too, but the immediate danger in anaphylaxis is the development of life-threatening airway, breathing or circulatory compromise.

The rash is improving. Why might the patient still be getting worse?

Go back to our patient.

They developed urticaria after the antibiotic. An antihistamine was given. The itching settles and the wheals begin to fade.

Then they say:

“My throat feels funny.”

Their voice sounds different. They are becoming light-headed.

If you judge the reaction by the skin, the treatment appears to be working. If you assess the patient, the situation is moving in the opposite direction.

The antihistamine can reduce an H1-mediated skin symptom while the systemic reaction continues. Upper-airway oedema may be developing. Widespread vasodilation and increased vascular permeability may be reducing effective circulating volume.

That is why “the rash looks better” is not the same as “the patient is better”.

For a student nurse, this is one of the most useful lessons in the whole topic. Do not let the most visible symptom become the only symptom you assess.

Why does adrenaline work when an antihistamine cannot?

Once you understand the physiology, adrenaline stops feeling like a random emergency drug you just have to memorise.

Adrenaline acts at alpha and beta adrenergic receptors, so it tackles several of the dangerous physiological changes at the same time.

Alpha-1 receptor stimulation causes vasoconstriction. That helps oppose the widespread vasodilation contributing to hypotension and can reduce mucosal oedema.

Beta-1 receptor stimulation increases cardiac activity, supporting the circulation.

Beta-2 receptor stimulation promotes bronchodilation and can reduce further mediator release from mast cells and basophils.

Compare that with an H1 antihistamine, which is mainly blocking one receptor pathway.

That is the logic behind intramuscular adrenaline being the first-line drug for suspected anaphylaxis. In the UK adult healthcare algorithm, Resuscitation Council UK recommends IM adrenaline 500 micrograms using the 1 mg/mL preparation at first suspicion of anaphylaxis, with a repeat dose after 5 minutes if there is no improvement. Dose and approach differ for children, so students should follow the age-appropriate emergency algorithm and local policy rather than trying to generalise the adult dose.

As a student, your role depends on your competence, supervision and clinical area. The crucial thing is that you recognise the deterioration, call for help and do not allow an antihistamine to create false reassurance or delay emergency management.

What about hydrocortisone?

This is another area where older teaching can linger.

You may still hear the traditional combination of “adrenaline, antihistamine and hydrocortisone” spoken about as though all three are equally important in the immediate treatment of anaphylaxis. They are not.

Resuscitation Council UK no longer recommends corticosteroids such as hydrocortisone for the routine initial treatment of anaphylaxis. They do not replace adrenaline and should not distract from managing airway, breathing and circulation.

That does not mean corticosteroids have no clinical uses. It means their role should not be confused with the immediate life-saving treatment of anaphylaxis.

For students, the hierarchy is more useful than memorising a drug bundle: recognise ABC compromise → escalate → IM adrenaline → continue ABCDE management and reassessment.

Why does positioning matter so much?

Imagine the circulation during anaphylaxis. Vessels are dilated and fluid is moving out of the intravascular space. Effective circulating volume may already be reduced.

Now make the patient stand suddenly.

Gravity causes further pooling of blood in the lower body, venous return to the heart can fall further and cardiovascular collapse may worsen. This is why someone with suspected anaphylaxis should not simply stand or walk because they say they feel a little better.

Positioning depends on the dominant clinical problem. A patient with circulatory compromise is generally kept lying flat, with leg elevation where appropriate. A patient with significant breathing difficulty may need to sit up. Pregnant patients require appropriate positioning to reduce aortocaval compression.

The exact position is not a piece of trivia. It follows from the physiology you are trying to support.

What happens around the adrenaline?

Adrenaline is first-line, but anaphylaxis management is not “give an injection and wait”.

The patient needs an ABCDE approach, urgent help, removal or stopping of the suspected trigger where feasible, appropriate monitoring and repeated reassessment.

High-concentration oxygen may be required in significant anaphylaxis. Intravenous access and IV crystalloid fluid are important when there is cardiovascular compromise because vasodilation and capillary leak can produce substantial relative and absolute intravascular volume loss. Further management depends on the patient's response and the emergency team.

What matters for you as a student is understanding why the team is doing these things. Oxygen supports oxygenation. Fluid helps restore the intravascular volume available to the circulation. Adrenaline addresses several major components of the reaction. Monitoring tells you whether those interventions are actually changing the patient's physiology.

And reassessment is continuous. A blood pressure from five minutes ago is not the patient's blood pressure now.

Where do sedating and non-sedating antihistamines fit?

Not all antihistamines behave identically.

Older first-generation H1 antihistamines, such as chlorphenamine, can cross the blood-brain barrier more readily and may cause sedation. They can also produce anticholinergic adverse effects.

Second-generation antihistamines such as cetirizine are generally less sedating and are often preferred when an oral antihistamine is being used for persistent skin symptoms after the patient has been stabilised.

Why should a student care about the sedation?

Because drowsiness is not a particularly helpful new symptom in a patient you are trying to assess for clinical deterioration. Medicines do not exist separately from assessment. If a patient becomes sleepy, you need to know what they have received and consider the whole clinical picture rather than automatically attributing the change to either the medicine or the reaction.

What should you notice on placement?

Suppose you are looking after someone receiving an IV antibiotic. Five minutes into the infusion they say they feel itchy.

Your job is not to diagnose the immunology at the bedside. Start by looking at the patient and establishing what has changed.

Is there a rash? Where did it begin? Is there lip, tongue or facial swelling? Has their voice changed? Can they swallow normally? Are they wheezing? Has their respiratory rate changed? What are their oxygen saturations? What is happening to their pulse and blood pressure? Are they dizzy, clammy or becoming confused?

Then look at the timeline. What was being administered? When was it started? When did the symptoms begin? Has the suspected trigger been stopped where appropriate? What treatment has already been given, and what happened after it?

This is the difference between documenting “allergic reaction, antihistamine given” and actually capturing useful clinical information.

A much more meaningful account describes the features and progression: for example, widespread urticaria developing several minutes after an antibiotic infusion, followed by voice change and hypotension, with the times of escalation, adrenaline administration and response recorded.

NICE's current anaphylaxis guidance specifically emphasises documenting the acute clinical features, time of onset and circumstances immediately before the reaction. That information matters for immediate care and later investigation.

And what happens after the emergency?

A patient improving after adrenaline is reassuring, but it does not mean everyone packs up immediately.

Symptoms can recur after apparent resolution, so observation after anaphylaxis is based on clinical risk rather than one fixed time for everybody. NICE updated its anaphylaxis guideline in May 2026 and now uses a risk-stratified approach to observation, aligned with Resuscitation Council UK guidance.

After emergency treatment for suspected anaphylaxis, appropriate follow-up includes referral to a specialist allergy service. The suspected trigger and reaction need to be recorded clearly, and the patient may require education and an adrenaline auto-injector plan depending on their individual circumstances.

That later work matters because “allergy” written vaguely in a record can create problems in both directions. A genuine severe allergy may not be communicated properly, while an inaccurate allergy label can unnecessarily restrict future treatment choices.

Bring it back to the patient

The easiest way to remember this topic is not to memorise separate lists for allergy, antihistamines and anaphylaxis. Keep the chain connected.

The sensitised patient encounters the allergen. IgE-mediated mast-cell activation releases histamine and other mediators. Histamine contributes to itching, urticaria, vasodilation and increased vascular permeability. An H1 antihistamine can reduce some of those histamine-mediated symptoms.

But if the reaction progresses to life-threatening airway, breathing or circulation problems, you are no longer trying to make the rash disappear. You are trying to support a threatened airway, ventilation and circulation.

That is why the treatment changes.

Antihistamine for the histamine-mediated symptoms. IM adrenaline for anaphylaxis.

And if you remember only one bedside lesson from the whole article, make it this: watch the patient, not just the rash.

References

Resuscitation Council UK (2025). Special circumstances guidelines: management and prevention of cardiac arrest due to anaphylaxis. Available at: Resuscitation Council UK 2025 guidelines.

Resuscitation Council UK (2021). Emergency treatment of anaphylaxis: Guidelines for healthcare providers. Available at: Emergency treatment of anaphylaxis.

National Institute for Health and Care Excellence (NICE) (2026). Anaphylaxis: assessment and referral after emergency treatment (NG258). Available at: NICE NG258.

Nursing and Midwifery Council (NMC) (2018, updated 2025). The Code: Professional standards of practice and behaviour for nurses, midwives and nursing associates. Available at: NMC Code.

This article is for student learning and placement preparation. Follow the emergency procedures, medicines guidance and escalation processes used in your placement area and work within your level of competence.